Detalles de la búsqueda
1.
The efficacy and safety of anamorelin among patients with diabetes.
Int J Clin Oncol;
2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722487
2.
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051.
Sci Rep;
14(1): 3816, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38360906
3.
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
Int J Clin Oncol;
29(2): 96-102, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183554
4.
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma.
JTO Clin Res Rep;
5(1): 100613, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229769
5.
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer.
Thorac Cancer;
15(6): 477-485, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243641
6.
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second-line chemotherapy in patients with small cell lung cancer.
Thorac Cancer;
14(35): 3475-3482, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37873674
7.
MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Letter.
Clin Cancer Res;
29(14): 2735, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449359
8.
Attenuation of LPS-Induced Lung Injury by Benziodarone via Reactive Oxygen Species Reduction.
Int J Mol Sci;
24(12)2023 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37373184
9.
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study).
Eur J Cancer;
184: 62-72, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905770
10.
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study.
J Cachexia Sarcopenia Muscle;
14(3): 1274-1285, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36905129
11.
Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines.
Cancers (Basel);
15(4)2023 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831513
12.
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
Thorac Cancer;
14(5): 442-449, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36523162
13.
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
BMC Cancer;
22(1): 1047, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203123
14.
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Lung Cancer;
172: 1-8, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35952438
15.
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID-19 infection.
Thorac Cancer;
13(18): 2654-2658, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35903864
16.
Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis.
JTO Clin Res Rep;
3(4): 100309, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35434666
17.
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
BMC Cancer;
22(1): 323, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337281
18.
Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.
Thorac Cancer;
12(22): 3076-3079, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617405
19.
Impact of the generation of EGFR-TKIs administered as prior therapy on the efficacy of osimertinib in patients with non-small cell lung cancer harboring EGFR T790M mutation.
Thorac Cancer;
12(3): 329-338, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219754
20.
Atezolizumab-induced fulminant type 1 diabetes mellitus occurring four months after treatment cessation.
Respirol Case Rep;
8(9): e00685, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33224504